Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹10.1 CrQualified E49 5 2ND FLOOR OKHLA INDUSTRIAL AREA PHASE 2 DELHI DELHI 110020 | SOUTH EAST DELHI | DELHI | 110020 | L1 | Qualified |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
15 Jan 2022, 5:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
BOQ (Q3) (High throughput Next Generation Sequencing platform)
3018081
GEM/2022/B/1830380
GeM Contract
BOQ
GeM Contract
Unknown (Unspecified Location)
Total value wise evaluation
BOQ
Awarded to PREMAS LIFE SCIENCES PRIVATE LIMITED
₹10.1 Cr
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| High throughput Next Generation Sequencing platform | Illumina / Novaseq 6000 Sequencing System | 90275090 | 1 no | 101,000,000 | 101,000,000 |
6 documents required · 6 mandatory
1 yrs
₹50 L
50%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| BOQ (Q3) (High throughput Next Generation Sequencing platform) | - | 1 | - |
Exempted
16 Feb 2022
5 Jan 2022
15 Jan 2022
contract_GEMC-511687715073702.pdf
GeM contract · Paid plans only
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_3018081.pdf
GEM_BID
details-specifications-of-next-generation-sequencin_2022-01-05-15-22-27_e0085747908f386e43d20b79dd6ce2ee.pdf
BOQ
4092573.pdf
OTHER
termsCondition.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .